These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Unusual recurrence of pleomorphic xanthoastrocytoma. Razzaq AA, Akula M, Mathew B. Br J Neurosurg; 2006 Dec; 20(6):433-4. PubMed ID: 17439101 [No Abstract] [Full Text] [Related]
3. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ. Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [Abstract] [Full Text] [Related]
4. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Knopp EA, Johnson G. Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838 [Abstract] [Full Text] [Related]
13. [The role of PET-FDG in questionable diagnosis of relapse in the presence of radionecrosis of brain tumors]. Asensio C, Pérez-Castejón MJ, Maldonado A, Montz R, Ruiz JA, Santos M, García-Berrocal I, Albert J, Carreras JL. Rev Neurol; 1998 Sep; 27(157):447-52. PubMed ID: 9774817 [Abstract] [Full Text] [Related]
18. Metastatic oligodendrogliomas: a review of the literature and case report. Zustovich F, Della Puppa A, Scienza R, Anselmi P, Furlan C, Cartei G. Acta Neurochir (Wien); 2008 Jul; 150(7):699-702; discussion 702-3. PubMed ID: 18548193 [Abstract] [Full Text] [Related]